Ras, PI(3)K and mTOR signalling controls tumour cell growth
- PMID: 16724053
- DOI: 10.1038/nature04869
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Abstract
All eukaryotic cells coordinate cell growth with the availability of nutrients in their environment. The mTOR protein kinase has emerged as a critical growth-control node, receiving stimulatory signals from Ras and phosphatidylinositol-3-OH kinase (PI(3)K) downstream from growth factors, as well as nutrient inputs in the form of amino-acid, glucose and oxygen availability. Notably, components of the Ras and PI(3)K signalling pathways are mutated in most human cancers. The preponderance of mutations in these interconnected pathways suggests that the loss of growth-control checkpoints and promotion of cell survival in nutrient-limited conditions may be an obligate event in tumorigenesis.
Similar articles
-
[Targeting Ras-PI3K/mTOR pathway and the predictive biomarkers in endometrial cancer].Gan To Kagaku Ryoho. 2011 Jul;38(7):1084-7. Gan To Kagaku Ryoho. 2011. PMID: 21772091 Japanese.
-
Mechanical stimuli regulate rapamycin-sensitive signalling by a phosphoinositide 3-kinase-, protein kinase B- and growth factor-independent mechanism.Biochem J. 2004 Jun 15;380(Pt 3):795-804. doi: 10.1042/BJ20040274. Biochem J. 2004. PMID: 15030312 Free PMC article.
-
EGF-induced activation of Akt results in mTOR-dependent p70S6 kinase phosphorylation and inhibition of HC11 cell lactogenic differentiation.BMC Cell Biol. 2006 Sep 19;7:34. doi: 10.1186/1471-2121-7-34. BMC Cell Biol. 2006. PMID: 16984645 Free PMC article.
-
[Advances on PI3K/Akt/mTOR signalling pathway in malignancies].Zhonghua Bing Li Xue Za Zhi. 2005 Oct;34(10):674-6. Zhonghua Bing Li Xue Za Zhi. 2005. PMID: 16536284 Review. Chinese. No abstract available.
-
Ras and phosphoinositide 3-kinase: partners in development and tumorigenesis.Cell Cycle. 2007 Dec 1;6(23):2902-5. doi: 10.4161/cc.6.23.4996. Epub 2007 Aug 31. Cell Cycle. 2007. PMID: 17993782 Review.
Cited by
-
miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma.Sci Rep. 2024 Aug 2;14(1):17967. doi: 10.1038/s41598-024-69070-7. Sci Rep. 2024. PMID: 39095540 Free PMC article.
-
Phase Ib and pharmacokinetics study of alpelisib, a PIK3CA inhibitor, and capecitabine in patients with advanced solid tumors.Front Oncol. 2024 Jul 12;14:1390452. doi: 10.3389/fonc.2024.1390452. eCollection 2024. Front Oncol. 2024. PMID: 39070139 Free PMC article.
-
A review of the botany, phytochemistry, pharmacology, synthetic biology and comprehensive utilization of Silybum marianum.Front Pharmacol. 2024 Jul 11;15:1417655. doi: 10.3389/fphar.2024.1417655. eCollection 2024. Front Pharmacol. 2024. PMID: 39055491 Free PMC article. Review.
-
Inhibition of Prostate Cancer Cell Survival and Proliferation by Carnosic Acid Is Associated with Inhibition of Akt and Activation of AMPK Signaling.Nutrients. 2024 Apr 24;16(9):1257. doi: 10.3390/nu16091257. Nutrients. 2024. PMID: 38732504 Free PMC article.
-
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies.Pathol Oncol Res. 2024 Mar 7;30:1611643. doi: 10.3389/pore.2024.1611643. eCollection 2024. Pathol Oncol Res. 2024. PMID: 38515456 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous